GLTO
Price
$3.42
Change
-$0.08 (-2.29%)
Updated
Jun 27 closing price
Capitalization
4.52M
XERS
Price
$4.70
Change
-$0.04 (-0.84%)
Updated
Jun 27 closing price
Capitalization
752.73M
38 days until earnings call
Interact to see
Advertisement

GLTO vs XERS

Header iconGLTO vs XERS Comparison
Open Charts GLTO vs XERSBanner chart's image
Galecto
Price$3.42
Change-$0.08 (-2.29%)
Volume$13.44K
Capitalization4.52M
Xeris Biopharma Holdings
Price$4.70
Change-$0.04 (-0.84%)
Volume$4.69M
Capitalization752.73M
GLTO vs XERS Comparison Chart in %
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. XERS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and XERS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GLTO: $3.42 vs. XERS: $4.70)
Brand notoriety: GLTO and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 26% vs. XERS: 215%
Market capitalization -- GLTO: $4.52M vs. XERS: $752.73M
GLTO [@Biotechnology] is valued at $4.52M. XERS’s [@Biotechnology] market capitalization is $752.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, GLTO is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 5 TA indicator(s) are bullish while XERS’s TA Score has 5 bullish TA indicator(s).

  • GLTO’s TA Score: 5 bullish, 4 bearish.
  • XERS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XERS is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а +1.48% price change this week, while XERS (@Biotechnology) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($753M) has a higher market cap than GLTO($4.52M). XERS YTD gains are higher at: 38.643 vs. GLTO (-26.456). XERS has higher annual earnings (EBITDA): -4.34M vs. GLTO (-18.06M). XERS has more cash in the bank: 58.4M vs. GLTO (11.9M). GLTO has less debt than XERS: GLTO (73K) vs XERS (269M). XERS has higher revenues than GLTO: XERS (223M) vs GLTO (0).
GLTOXERSGLTO / XERS
Capitalization4.52M753M1%
EBITDA-18.06M-4.34M416%
Gain YTD-26.45638.643-68%
P/E RatioN/AN/A-
Revenue0223M-
Total Cash11.9M58.4M20%
Total Debt73K269M0%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOXERS
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AILCX17.170.18
+1.06%
American Beacon International Eq C
PRJZX47.170.25
+0.53%
PGIM Jennison Global Opportunities Z
ESCGX11.600.05
+0.43%
Ashmore Emerging Markets Equity ESG C
HADAX30.860.08
+0.26%
Hartford Balanced HLS IA
FMEFX41.840.09
+0.22%
Nuveen Small/Mid Cap Growth Opp R6

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
-2.29%
TCRT - GLTO
56%
Loosely correlated
+2.19%
XERS - GLTO
39%
Loosely correlated
-0.84%
VIVS - GLTO
38%
Loosely correlated
+2.11%
CYTK - GLTO
36%
Loosely correlated
-2.21%
SYRE - GLTO
35%
Loosely correlated
-4.99%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-0.84%
TRDA - XERS
51%
Loosely correlated
-1.57%
YMAB - XERS
45%
Loosely correlated
-2.08%
XNCR - XERS
45%
Loosely correlated
-3.10%
CGON - XERS
44%
Loosely correlated
-0.46%
KRYS - XERS
43%
Loosely correlated
-2.60%
More